Canine Elbow Dysplasia: Diagnosis and Management

Canine elbow dysplasia (ED) is a complex developmental condition affecting the elbow joint, primarily in medium to large breed dogs. It encompasses several specific pathologies including fragmented medial coronoid process (FCP), ununited anconeal process (UAP), osteochondritis dissecans (OCD), and elbow incongruity. These conditions lead to pain, lameness, and progressive osteoarthritis. This article provides veterinary clinicians with an evidence-based framework for diagnosing and managing ED, covering pathophysiology, breed predisposition, diagnostic imaging, medical and surgical treatment options, and long-term monitoring strategies.

At a Glance: Canine Elbow Dysplasia Overview

Pathophysiology of Canine Elbow Dysplasia

Elbow dysplasia results from abnormal development of the elbow joint during growth. The condition is multifactorial, involving genetic predisposition, rapid growth rate, nutrition, and biomechanical stress. The elbow is a complex hinge joint formed by the humerus, radius, and ulna. Proper articulation of these three bones is essential for normal joint function. Any disruption in growth or alignment can lead to abnormal forces across the joint surfaces, initiating a cascade of pathological changes.

The primary lesions of ED include FCP, UAP, OCD, and elbow incongruity. These lesions often occur in combination instead of in isolation. For example, a dog with elbow incongruity may develop secondary FCP due to abnormal loading of the medial coronoid process. The Merck Veterinary Manual provides an overview of musculoskeletal disorders in dogs, including developmental conditions like elbow dysplasia (Merck Veterinary Manual).

Fragmented medial coronoid process is the most common manifestation of ED. The medial coronoid process is a bony projection on the proximal ulna that articulates with the humerus. During weight bearing, this area experiences high compressive forces. In susceptible dogs, the coronoid process may develop a fissure or fragment, leading to pain, inflammation, and cartilage damage. The exact cause of fragmentation is debated, but it is thought to involve abnormal loading, microtrauma, and possibly ischemic necrosis.

Ununited anconeal process involves failure of the anconeal process to fuse to the proximal ulnar metaphysis. The anconeal process normally ossifies from a separate center and fuses by 20 to 24 weeks of age. If fusion does not occur, the anconeal process remains as a separate bone fragment, causing joint instability and pain. UAP is more common in German Shepherds and other large breeds. A review of UAP in the veterinary literature describes its pathogenesis and diagnostic features (Review on canine elbow dysplasia: pathogenesis, diagnosis, prevalence and genetic aspects, DTW. Deutsche tierarztliche Wochenschrift, 2008).

Osteochondritis dissecans of the elbow involves a flap of cartilage that partially or completely detaches from the medial humeral condyle. This lesion is part of the osteochondrosis spectrum, where abnormal endochondral ossification leads to thickened, weakened cartilage that is prone to fissuring. The cartilage flap can cause mechanical irritation and inflammation within the joint.

Elbow incongruity refers to a mismatch in the articular surfaces of the humerus, radius, and ulna. This can result from asynchronous growth of the radius and ulna, leading to a step defect at the joint surface. Incongruity alters load distribution across the joint, predisposing to secondary lesions such as FCP and accelerated osteoarthritis. Advances in diagnostic imaging have improved the ability to detect subtle incongruities (Role of Elbow Incongruity in Canine Elbow Dysplasia: Advances in Diagnostics and Biomechanics, Veterinary and Comparative Orthopaedics and Traumatology, 2019).

Breed Predisposition and Genetic Factors

Elbow dysplasia has a strong breed predisposition, with certain breeds showing significantly higher prevalence. Large and giant breed dogs are most commonly affected. The condition is heritable, with multiple genes likely involved. Breeding programs in many countries use radiographic screening to reduce the incidence of ED.

Labrador Retrievers are one of the most commonly affected breeds. A study of UK Labrador Retrievers found that elbow dysplasia is a significant health concern in this breed (Canine hip and elbow dysplasia in UK Labrador retrievers, Veterinary Journal, 2011). Golden Retrievers, Rottweilers, and Bernese Mountain Dogs also have high prevalence rates. German Shepherds are particularly predisposed to UAP, while other large breeds may develop FCP or OCD more frequently.

The heritability of ED varies by breed and population. Estimates range from 0.1 to 0.4, indicating a moderate genetic component. Environmental factors such as nutrition, growth rate, and exercise also play a role. Rapid growth and excessive caloric intake during puppyhood are associated with increased risk of developmental orthopedic diseases. The World Organisation for Animal Health (WOAH) provides guidelines for animal health and welfare, including considerations for breeding practices that can reduce the prevalence of hereditary conditions (Animal Health and Welfare, World Organisation for Animal Health).

Veterinarians should be aware of breed-specific risk when evaluating young dogs with forelimb lameness. A thorough history including breed, age, and family history of ED can guide diagnostic planning. For breeds with high prevalence, early screening may be warranted, especially if the dog is intended for breeding.

Clinical Presentation and Physical Examination

Dogs with elbow dysplasia typically present with forelimb lameness that may be intermittent or persistent. Onset is usually between 4 and 18 months of age, though some dogs may not show signs until later in life as osteoarthritis progresses. Lameness is often worse after exercise or following periods of rest. Bilateral involvement is common, and owners may report stiffness or reluctance to exercise.

Physical examination findings include pain on manipulation of the elbow joint, particularly during extension and flexion. Crepitus may be palpable as the joint moves. Joint effusion may be detected as swelling on the lateral aspect of the elbow. Muscle atrophy of the affected limb may develop over time, especially in chronic cases.

Specific orthopedic tests can help localize the source of lameness. The elbow flexion test involves holding the elbow in full flexion for 30 to 60 seconds. A positive test is indicated by increased lameness or reluctance to bear weight after release. This test is suggestive of elbow pathology but is not specific for ED.

Differential diagnoses for forelimb lameness in young large breed dogs include panosteitis, hypertrophic osteodystrophy, shoulder OCD, and soft tissue injuries. A systematic approach to lameness evaluation is essential. The American Animal Hospital Association (AAHA) provides resources for diagnostic and treatment guidelines in small animal practice (AAHA Resources).

Diagnostic Imaging

Radiography

Radiography is the initial imaging modality for suspected elbow dysplasia. Standard views include mediolateral, craniocaudal, and flexed lateral projections. The flexed lateral view is particularly useful for evaluating the anconeal process. Radiographic signs of ED vary depending on the specific lesion present.

For FCP, radiographic findings may include sclerosis of the ulnar trochlear notch, blunting or irregularity of the medial coronoid process, and secondary osteophyte formation. However, radiography has limited sensitivity for detecting FCP, as the fragment may be small or non-mineralized. Many dogs with FCP have normal radiographs, especially in early stages.

UAP is more readily identified on radiography. The flexed lateral view shows a separate, non-fused anconeal process in dogs older than 24 weeks. The fragment may be displaced or in normal position. Computed tomography (CT) provides more detailed assessment of UAP morphology and associated changes (Computed tomography of ununited anconeal process in the dog, Veterinary and Comparative Orthopaedics and Traumatology, 2012).

OCD lesions appear as a concave defect on the medial humeral condyle, often with a mineralized cartilage flap visible. Subchondral bone sclerosis may be present adjacent to the lesion. Elbow incongruity is assessed by evaluating the alignment of the radial head and coronoid process relative to the humeral condyle.

Radiographic screening for ED is performed by organizations such as the Orthopedic Foundation for Animals (OFA) and the British Veterinary Association/Kennel Club (BVA/KC). These schemes grade elbows based on the presence and severity of osteophytes, sclerosis, and other changes. A normal elbow grade does not guarantee absence of ED, as early lesions may not be radiographically visible.

Computed Tomography

CT is superior to radiography for evaluating elbow dysplasia. It provides detailed cross-sectional images of the joint, allowing assessment of the coronoid process, anconeal process, humeral condyle, and articular congruity. CT is particularly valuable for detecting FCP, which may be missed on radiographs. The sensitivity of CT for FCP is high, and it can identify fissures, fragments, and associated cartilage changes.

CT is also useful for surgical planning. Three-dimensional reconstructions can help the surgeon visualize the lesion location and plan arthroscopic or open approaches. For UAP, CT can assess fragment size, displacement, and the presence of secondary osteoarthritis. The role of CT in diagnosing elbow incongruity has been advanced by studies using weight-bearing CT and dynamic imaging (Role of Elbow Incongruity in Canine Elbow Dysplasia: Advances in Diagnostics and Biomechanics, Veterinary and Comparative Orthopaedics and Traumatology, 2019).

Arthroscopy

Arthroscopy is considered the gold standard for diagnosing and treating certain forms of elbow dysplasia. It allows direct visualization of the articular surfaces, including the medial coronoid process, humeral condyle, and anconeal process. Arthroscopy can identify cartilage lesions, fragments, and synovial changes that may not be visible on imaging.

Therapeutic arthroscopy enables fragment removal, cartilage debridement, and joint lavage. For FCP, arthroscopic removal of fragmented pieces can improve clinical signs. However, not all fragments are amenable to arthroscopic removal, and some dogs may require open arthrotomy. Arthroscopy is also used to assess elbow incongruity, though the interpretation of subtle incongruity remains challenging.

Medical Management

Medical management of elbow dysplasia focuses on controlling pain, reducing inflammation, slowing osteoarthritis progression, and maintaining function. It is indicated for dogs with mild clinical signs, those that are not surgical candidates, and as adjunctive therapy after surgery.

Weight Management

Maintaining optimal body condition is one of the most important aspects of managing elbow dysplasia. Excess body weight increases load on the elbow joint, exacerbating pain and accelerating osteoarthritis. A lean body condition score (4-5 out of 9) is recommended. Caloric restriction should be implemented if the dog is overweight. Regular monitoring of body weight and condition score is essential.

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

NSAIDs are the mainstay of pharmacological pain management for elbow dysplasia. They reduce inflammation and provide analgesia. Commonly used NSAIDs in dogs include carprofen, meloxicam, firocoxib, and deracoxib. Selection should be based on individual patient factors, including age, renal function, and gastrointestinal tolerance.

NSAIDs should be used at the lowest effective dose and for the shortest duration necessary. Baseline blood work, including renal and hepatic parameters, is recommended before initiating therapy. Periodic monitoring is advised for dogs on long-term NSAID therapy. Concurrent use of corticosteroids or other NSAIDs is contraindicated due to increased risk of gastrointestinal ulceration and renal injury.

Joint Supplements

Nutraceuticals such as glucosamine, chondroitin sulfate, and omega-3 fatty acids are commonly used in dogs with osteoarthritis. Evidence for their efficacy is variable, but they may provide symptomatic benefit in some dogs. Omega-3 fatty acids, particularly eicosapentaenoic acid (EPA), have anti-inflammatory properties and may slow cartilage degradation.

Other supplements include green-lipped mussel extract, hyaluronic acid, and avocado soybean unsaponifiables. The quality and bioavailability of these products vary. Veterinarians should recommend products from reputable manufacturers with published quality control data.

Physical Rehabilitation

Physical therapy plays an important role in managing elbow dysplasia. Therapeutic exercises can improve range of motion, strengthen supporting muscles, and reduce pain. Modalities such as therapeutic laser, extracorporeal shockwave therapy, and hydrotherapy may provide additional benefit. A study on the diagnosis of canine elbow dysplasia and treatment with extracorporeal shockwave therapy has been published, though specific protocols are not detailed here (Diagnosis of canine elbow dysplasia and treatment with extracorporeal shockwave therapy, Journal of the American Veterinary Medical Association, 2026).

A rehabilitation program should be tailored to the individual dog's needs and response. Passive range of motion exercises, controlled leash walks, and swimming are common components. High-impact activities such as jumping and running on hard surfaces should be avoided.

Surgical Management

Surgical intervention is indicated for dogs with persistent lameness despite medical management, those with significant lesions identified on imaging, and young dogs with FCP, UAP, or OCD. The goal of surgery is to remove loose fragments, restore joint congruity, and delay the onset of osteoarthritis.

Arthroscopic Fragment Removal

Arthroscopic removal of fragmented coronoid process is a common procedure. The surgeon visualizes the medial compartment and removes loose cartilage or bone fragments. Debridement of fissured cartilage and synovium may also be performed. Arthroscopy is less invasive than open arthrotomy and allows faster recovery.

Outcomes after arthroscopic fragment removal are generally good, with most dogs showing improvement in lameness. However, progression of osteoarthritis is inevitable, and long-term medical management is still required. Factors associated with poorer outcomes include severe preoperative osteoarthritis, bilateral disease, and delayed surgical intervention.

Ulnar Osteotomy

Ulnar osteotomy is a surgical procedure used to treat UAP and certain cases of elbow incongruity. The goal is to alter the biomechanical forces across the elbow joint, allowing the anconeal process to fuse or reducing abnormal loading. Dynamic proximal ulnar osteotomy has been described for the treatment of UAP in dogs (Dynamic proximal ulnar osteotomy for the treatment of ununited anconeal process in 17 dogs, Veterinary and Comparative Orthopaedics and Traumatology, 1998).

The procedure involves creating an osteotomy in the proximal ulna, which allows the ulna to shift relative to the humerus. This can reduce pressure on the anconeal process and promote fusion. Success rates vary, and some dogs may require additional surgery. Postoperative management includes activity restriction and physical therapy.

Total Elbow Replacement

Total elbow replacement (TER) is a salvage procedure for dogs with severe, debilitating elbow osteoarthritis that is unresponsive to medical management. The procedure involves replacing the articular surfaces of the humerus and ulna with prosthetic components. TER is technically demanding and carries risks including infection, implant loosening, and fracture.

Candidate selection for TER is critical. Dogs should have severe pain and lameness that significantly impacts quality of life. They should be free of infection and have adequate bone stock to support the implants. Postoperative rehabilitation is extensive, and long-term outcomes are variable. TER is not widely performed and is typically referred to specialist orthopedic surgeons.

Records and Measurements

Accurate record keeping is essential for managing dogs with elbow dysplasia. The following parameters should be documented at each visit:

• Body weight and body condition score
• Lameness grade (e.g., 0-5 scale)
• Pain score on elbow manipulation
• Range of motion measurements (goniometry)
• Radiographic or CT findings
• Medical therapy (drug, dose, frequency, duration)
• Surgical details (procedure, findings, complications)
• Owner-reported outcomes (e.g., activity level, stiffness)

Serial measurements allow assessment of disease progression and response to treatment. Standardized lameness scoring systems, such as those used in clinical trials, can improve objectivity. The American College of Veterinary Internal Medicine (ACVIM) provides resources for evidence-based veterinary medicine, including guidelines for managing osteoarthritis (ACVIM).

Common Failure Patterns

Several factors can lead to suboptimal outcomes in dogs with elbow dysplasia. Recognizing these patterns can help clinicians adjust management strategies.

Delayed Diagnosis

Elbow dysplasia is often diagnosed late, after significant osteoarthritis has developed. Young dogs with subtle lameness may be dismissed as having growing pains or minor injuries. Delayed diagnosis reduces the window for early intervention, when surgical treatment may be most effective. Clinicians should maintain a high index of suspicion in predisposed breeds.

Incomplete Lesion Identification

Multiple lesions may coexist in the same elbow. For example, a dog with FCP may also have elbow incongruity or OCD. Failure to identify all lesions can lead to incomplete treatment and persistent lameness. Advanced imaging such as CT and arthroscopy is recommended for comprehensive evaluation.

Poor Compliance with Medical Management

Medical management requires ongoing commitment from the owner. Weight management, exercise restriction, and medication administration must be consistent. Owners who are unable or unwilling to follow recommendations may see poor outcomes. Clear communication and realistic goal setting are important.

Progression of Osteoarthritis

Despite optimal management, osteoarthritis will progress in most dogs with elbow dysplasia. The rate of progression varies. Some dogs maintain acceptable function for years, while others deteriorate rapidly. Regular monitoring and adjustment of therapy are necessary.

Welfare and Safety Context

Elbow dysplasia is a painful condition that can significantly impair a dog's quality of life. Chronic pain leads to reduced activity, muscle atrophy, and behavioral changes. Owners may misinterpret these signs as aging or laziness. Veterinarians have a responsibility to educate owners about the nature of the disease and the importance of pain management.

The World Organisation for Animal Health (WOAH) emphasizes the importance of animal health and welfare in veterinary practice (Animal Health and Welfare, World Organisation for Animal Health). Managing chronic pain is a core component of welfare. Multimodal analgesia, including NSAIDs, joint supplements, physical therapy, and weight management, should be employed.

Safety considerations include the risks associated with NSAID therapy, particularly in dogs with renal or hepatic disease. Owners should be informed about potential adverse effects and signs of toxicity. Surgical procedures carry anesthetic and surgical risks, which should be discussed with the owner before proceeding.

Professional Escalation Criteria

Veterinarians should consider referral to a specialist (veterinary orthopedic surgeon or rehabilitation specialist) in the following situations:

• Persistent lameness despite appropriate medical management for 4-8 weeks
• Severe lameness or non-weight-bearing lameness
• Suspected UAP or elbow incongruity requiring surgical correction
• Need for advanced imaging (CT, MRI) or arthroscopy
• Consideration of total elbow replacement
• Poor response to initial surgical treatment
• Complications such as infection or implant failure

Referral should also be considered for dogs with complex comorbidities or when the primary care veterinarian is not comfortable with the diagnostic or therapeutic plan. Early referral can improve outcomes and reduce the risk of irreversible joint damage.

Practical Decision Framework for Selecting Medical versus Surgical Management in Canine Elbow Dysplasia

Selecting between medical and surgical management for canine elbow dysplasia requires a systematic evaluation of patient-specific factors, lesion characteristics, and owner resources. No single treatment pathway applies to all cases, and the decision should be based on objective clinical findings instead of preference alone. This section provides a structured framework to guide clinicians through the decision-making process, incorporating lesion type, severity, patient age, and owner commitment.

Step 1: Confirm the Primary Lesion Type and Severity

The first decision point is identifying which specific elbow dysplasia lesion is present and its severity. This requires diagnostic imaging beyond radiography in most cases. The Merck Veterinary Manual notes that elbow dysplasia encompasses multiple developmental abnormalities that require different management approaches (Merck Veterinary Manual).

For fragmented medial coronoid process (FCP), the decision hinges on fragment size, stability, and associated cartilage damage. Small, non-displaced fragments without significant cartilage erosion may respond to medical management, particularly in dogs with mild lameness. Large, displaced fragments or those causing mechanical locking typically require arthroscopic removal. A study on medial compartment disease and osteoarthritis in canine elbow dysplasia describes the progressive nature of FCP and the importance of early intervention (Canine Elbow Dysplasia: Medial Compartment Disease and Osteoarthritis, The Veterinary clinics of North America. Small animal practice, 2021).

For ununited anconeal process (UAP), surgical management is almost always indicated because the non-fused fragment causes persistent joint instability and pain. Medical management alone rarely resolves clinical signs in UAP cases. The fragment size and degree of displacement influence the specific surgical technique chosen. A review of UAP in the veterinary literature describes the pathogenesis and diagnostic features that guide surgical planning (Review on canine elbow dysplasia: pathogenesis, diagnosis, prevalence and genetic aspects, DTW. Deutsche tierarztliche Wochenschrift, 2008).

For osteochondritis dissecans (OCD), the decision depends on whether the cartilage flap is partially or completely detached. Small, stable flaps may heal with conservative management in young dogs, but most OCD lesions benefit from arthroscopic debridement and flap removal. The depth and location of the subchondral bone defect also influence prognosis.

For elbow incongruity, the decision is more complex. Mild incongruity may be managed medically, while moderate to severe incongruity often requires surgical correction through ulnar osteotomy or other realignment procedures. Advances in diagnostic imaging have improved the ability to detect subtle incongruities that may benefit from surgical intervention (Role of Elbow Incongruity in Canine Elbow Dysplasia: Advances in Diagnostics and Biomechanics, Veterinary and Comparative Orthopaedics and Traumatology, 2019).

Step 2: Assess Patient Age and Disease Chronicity

Patient age at presentation is a critical factor in the decision framework. Dogs presenting between 4 and 12 months of age with acute or subacute lameness are the best candidates for surgical intervention. At this stage, osteoarthritis is minimal, and surgical correction can alter the disease trajectory. Delaying surgery in young dogs allows irreversible joint damage to develop.

Dogs presenting between 12 and 24 months of age may still benefit from surgery, but the presence of established osteoarthritis reduces the likelihood of complete resolution. The decision should balance the potential benefit of fragment removal against the inevitable progression of osteoarthritis. Owners should be counseled that surgery at this stage aims to reduce pain and slow disease progression instead of cure the condition.

Dogs presenting after 24 months of age with chronic lameness and radiographic osteoarthritis are generally managed medically unless they have a specific surgical indication such as a large loose fragment causing mechanical locking or severe pain unresponsive to medical therapy. Total elbow replacement may be considered in end-stage disease, but this is reserved for dogs with severe, debilitating pain.

Step 3: Evaluate Lameness Severity and Functional Impact

Objective assessment of lameness severity guides the decision between medical and surgical management. A standardized lameness grading system should be used:

• Grade 0: No lameness observed
• Grade 1: Mild lameness, weight-bearing on the affected limb
• Grade 2: Moderate lameness, intermittent non-weight-bearing
• Grade 3: Severe lameness, consistent non-weight-bearing
• Grade 4: Non-weight-bearing lameness at all times

Dogs with grade 0 or 1 lameness may be candidates for medical management, particularly if the lesion is mild and the dog is older. Dogs with grade 2 or higher lameness that persists despite 4 to 6 weeks of appropriate medical therapy should be considered for surgical intervention. The American Animal Hospital Association provides resources for diagnostic and treatment guidelines that emphasize the importance of objective lameness assessment (AAHA Resources).

Functional impact should also be assessed through owner-reported outcomes. Questions about the dog's ability to climb stairs, jump into vehicles, play, and perform daily activities provide valuable information. Dogs that cannot perform normal activities despite medical management are surgical candidates.

Step 4: Consider Bilateral Involvement

Elbow dysplasia is bilateral in 30 to 50 percent of cases, and this should influence the decision framework. Dogs with bilateral disease may have more severe functional impairment and may benefit from staged surgical intervention. The decision to operate on both elbows simultaneously or sequentially depends on the dog's overall condition, owner resources, and the severity of each limb.

For dogs with unilateral disease, the contralateral limb should be monitored closely. Owners should be educated about signs of lameness in the other limb. Radiographic screening of the contralateral elbow is recommended even if the dog is not lame on that side, as early lesions may be present.

Step 5: Evaluate Owner Resources and Commitment

Owner factors are often the limiting factor in surgical decision-making. Surgical management requires financial investment, postoperative care, activity restriction for 6 to 12 weeks, and commitment to physical rehabilitation. Owners who cannot provide these resources may be better served by aggressive medical management.

Key owner factors to assess include:

• Financial resources for surgery, imaging, and postoperative care
• Ability to restrict activity for the required period
• Access to physical rehabilitation services
• Willingness to administer medications and monitor for side effects
• Realistic expectations about outcomes

Owners should be counseled that surgery does not cure elbow dysplasia and that osteoarthritis will progress regardless of treatment. The goal of surgery is to reduce pain and improve function, not to create a normal joint. A study on canine elbow dysplasia in UK Labrador retrievers highlights the importance of owner education in managing this chronic condition (Canine hip and elbow dysplasia in UK Labrador retrievers, Veterinary journal, 2011).

Step 6: Implement a Trial of Medical Management

For dogs with mild to moderate lameness and lesions that are not clearly surgical, a 4 to 6 week trial of medical management is appropriate. This trial should include:

• Weight management if the dog is overweight (body condition score target 4-5 out of 9)
• NSAID therapy at the labeled dose
• Joint supplements containing omega-3 fatty acids
• Activity modification (avoid jumping, running on hard surfaces, and prolonged exercise)
• Physical therapy (passive range of motion, controlled leash walks)

Response to the trial should be assessed objectively using the lameness grading system and owner-reported outcomes. Dogs that show significant improvement may continue with medical management. Dogs that show minimal or no improvement should be considered for surgical intervention.

Step 7: Consider Advanced Imaging Before Final Decision

If the decision between medical and surgical management remains unclear after initial evaluation, advanced imaging with computed tomography (CT) is indicated. CT provides detailed information about lesion morphology, fragment size and location, cartilage integrity, and joint congruity that cannot be obtained from radiography alone.

CT findings that favor surgical management include:

• Large, displaced fragments
• Multiple fragments
• Deep subchondral bone defects
• Significant elbow incongruity
• Evidence of mechanical impingement

CT findings that favor medical management include:

• Small, non-displaced fragments
• Minimal cartilage damage
• Mild incongruity without mechanical symptoms
• Absence of loose bodies

Arthroscopy may also be used as a diagnostic and therapeutic tool. It allows direct visualization of the articular surfaces and simultaneous treatment of identified lesions. Arthroscopy is particularly valuable for evaluating the medial coronoid process and humeral condyle.

Records and Measurements for Decision Tracking

A standardized record system should be used to track decision-making and outcomes for each patient. The following parameters should be documented at initial evaluation and at each follow-up visit:

• Date of evaluation
• Patient signalment (breed, age, sex, weight)
• Primary lesion type (FCP, UAP, OCD, incongruity)
• Lesion severity (mild, moderate, severe based on imaging)
• Lameness grade (0-4 scale)
• Pain score on elbow manipulation (0-3 scale)
• Range of motion measurements (flexion and extension in degrees)
• Body weight and body condition score
• Current medications (drug, dose, frequency)
• Owner-reported functional assessment
• Decision made (medical management, surgical management, or referral)
• Rationale for decision

Serial measurements allow objective assessment of disease progression and treatment response. A standardized lameness scoring system improves consistency between examinations and reduces subjective bias.

Common Failure Patterns in Decision-Making

Several common errors can lead to suboptimal outcomes in the decision-making process.

Delaying surgery in young dogs with surgical lesions is the most common failure pattern. Clinicians may attempt medical management for too long in dogs with FCP or UAP, allowing irreversible osteoarthritis to develop. The window for optimal surgical intervention is narrow, typically between 4 and 12 months of age.

Underestimating lesion severity based on radiography alone is another common error. Radiography has limited sensitivity for FCP and early OCD lesions. Dogs with normal radiographs may have significant pathology visible on CT or arthroscopy. Reliance on radiography alone can lead to inappropriate medical management.

Overestimating the benefit of surgery in older dogs with established osteoarthritis is also problematic. Surgery in dogs with advanced osteoarthritis may provide minimal benefit and carries the same risks as surgery in younger dogs. Owners should be counseled about realistic outcomes.

Failing to address bilateral disease is a common oversight. Dogs with unilateral lameness may have significant pathology in the contralateral limb that will become clinically apparent over time. Early identification and management of bilateral disease can improve long-term outcomes.

Welfare and Safety Context

The decision between medical and surgical management has significant welfare implications. Chronic pain from elbow dysplasia reduces quality of life and can lead to behavioral changes, muscle atrophy, and decreased activity. The World Organisation for Animal Health emphasizes the importance of managing chronic pain in animals (Animal Health and Welfare, World Organisation for Animal Health).

Surgery carries inherent risks including anesthetic complications, infection, implant failure, and postoperative pain. These risks must be weighed against the potential benefits of improved function and pain relief. Owners should be fully informed about the risks and benefits before making a decision.

Medical management also carries risks, particularly with long-term NSAID therapy. Renal and hepatic function should be monitored periodically in dogs on chronic NSAID therapy. Gastrointestinal side effects can occur, and owners should be educated about signs of toxicity.

Professional Escalation Criteria

Referral to a veterinary orthopedic specialist should be considered in the following situations:

• Uncertainty about the primary lesion type after initial imaging
• Complex lesions involving multiple components of elbow dysplasia
• Need for advanced imaging (CT, MRI) or arthroscopy
• Consideration of total elbow replacement
• Poor response to initial surgical treatment
• Complications such as infection or implant failure
• Owner request for second opinion

The American College of Veterinary Internal Medicine provides resources for evidence-based veterinary medicine that can guide referral decisions (ACVIM). Early referral can improve outcomes and reduce the risk of irreversible joint damage.

Summary of Decision Framework

The decision between medical and surgical management for canine elbow dysplasia should be based on a systematic evaluation of lesion type and severity, patient age, lameness severity, bilateral involvement, and owner resources. Young dogs with surgical lesions and persistent lameness are the best candidates for surgery. Older dogs with mild lesions and minimal lameness can be managed medically. A trial of medical management is appropriate for equivocal cases. Advanced imaging with CT or arthroscopy should be used when the decision remains unclear. Serial monitoring with standardized records allows objective assessment of treatment response and disease progression.

Frequently Asked Questions

What is the difference between fragmented coronoid process and ununited anconeal process?

Fragmented coronoid process (FCP) involves a fissure or fragment of the medial coronoid process of the ulna, while ununited anconeal process (UAP) is a failure of the anconeal process to fuse to the proximal ulna. FCP is more common in Labrador Retrievers and Golden Retrievers, while UAP is more common in German Shepherds. Both cause elbow pain and lameness, but they require different surgical approaches.

Can elbow dysplasia be cured?

Elbow dysplasia cannot be cured, as it is a developmental condition that leads to permanent changes in the joint. However, it can be managed effectively with a combination of medical and surgical treatments. The goal of management is to control pain, maintain function, and slow the progression of osteoarthritis. Many dogs with elbow dysplasia live comfortable lives with appropriate care.

At what age do dogs show signs of elbow dysplasia?

Clinical signs typically appear between 4 and 18 months of age, though some dogs may not show signs until later in life as osteoarthritis progresses. Early signs include intermittent forelimb lameness, stiffness after rest, and reluctance to exercise. Owners may notice the dog holding the affected limb out to the side when sitting.

Is elbow dysplasia hereditary?

Yes, elbow dysplasia has a strong genetic component. It is heritable in many breeds, including Labrador Retrievers, Golden Retrievers, Rottweilers, and German Shepherds. Breeding programs use radiographic screening to reduce the prevalence of the condition. Prospective owners should ask breeders about elbow screening results in the parents and grandparents.

What is the best diagnostic test for elbow dysplasia?

Computed tomography (CT) is the best diagnostic test for evaluating elbow dysplasia, as it provides detailed images of the coronoid process, anconeal process, and articular congruity. Arthroscopy is considered the gold standard for direct visualization of lesions and allows simultaneous treatment. Radiography is useful for screening but has limited sensitivity for early lesions.

Can elbow dysplasia be treated without surgery?

Yes, many dogs with mild to moderate elbow dysplasia can be managed medically. Treatment includes weight management, NSAIDs, joint supplements, physical therapy, and activity modification. Surgery is indicated for dogs with persistent lameness despite medical management, those with significant lesions such as UAP or large fragments, and young dogs where early intervention may improve outcomes.

What is the prognosis for a dog with elbow dysplasia?

The prognosis varies depending on the severity of the lesions, the age at diagnosis, and the response to treatment. Most dogs improve with appropriate management, but osteoarthritis will progress over time. Dogs with mild disease and good owner compliance often maintain acceptable function for many years. Dogs with severe disease may require salvage procedures such as total elbow replacement.

How can I prevent elbow dysplasia in my breeding program?

Prevention of elbow dysplasia relies on selective breeding. Dogs intended for breeding should undergo radiographic screening through organizations such as the Orthopedic Foundation for Animals (OFA) or the British Veterinary Association/Kennel Club (BVA/KC). Only dogs with normal elbow grades should be used for breeding. Additionally, maintaining appropriate growth rates through controlled nutrition and avoiding excessive exercise in puppies may reduce the risk.

Related Veterinary Guides

• Dog
• Canine Hyperadrenocorticism Cushings Diagnostic Management
• Dog Shedding Management
• How To Skin A Dog
• Arthritis In Dogs Symptoms And Diagnosis

References and Further Reading

• www.merckvetmanual.com
• www.aaha.org
• www.acvim.org
• Merck Veterinary Manual. Merck Veterinary Manual.
• Animal Health and Welfare. World Organisation for Animal Health.
• Canine Elbow Dysplasia: Medial Compartment Disease and Osteoarthritis.. The Veterinary clinics of North America. Small animal practice, 2021.
• Canine Elbow Dysplasia: Ununited Anconeal Process, Osteochondritis Dissecans, and Medial Coronoid Process Disease.. The Veterinary clinics of North America. Small animal practice, 2021.
• Diagnosis of canine elbow dysplasia and treatment with extracorporeal shockwave therapy.. Journal of the American Veterinary Medical Association, 2026.
• Canine hip and elbow dysplasia in UK Labrador retrievers.. Veterinary journal (London, England : 1997), 2011.
• Role of Elbow Incongruity in Canine Elbow Dysplasia: Advances in Diagnostics and Biomechanics.. Veterinary and comparative orthopaedics and traumatology : V.C.O.T, 2019.
• Review on canine elbow dysplasia: pathogenesis, diagnosis, prevalence and genetic aspects.. DTW. Deutsche tierarztliche Wochenschrift, 2008.
• Computed tomography of ununited anconeal process in the dog. Veterinary and Comparative Orthopaedics and Traumatology, 2012.
• Treatment reatment of ununited anconeal process in 8 dogs by osteotomy and dynamic distraction of the pro proximal part of the ulna. Pesquisa Veterinaria Brasileira, 2007.
• Ununited anconeal process in a Labrador retriever dog. Journal of Veterinary Clinics, 2008.
• Dynamic proximal ulnar osteotomy for the treatment of ununited anconeal process in 17 dogs. Veterinary and Comparative Orthopaedics and Traumatology, 1998.

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.